长春达兴药业股份有限公司
The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
長春達興药業股份有限公司
Changchun Da Xing Pharmaceutical Company Limited (a joint stock limited company incorporated in the People’s Republic of China)
(Stock Code :8067)
RECEIVE OF HKEX LETTER, SENTENCE OF FORMER
CHAIRMAN AND CFO
The Company has received, on January 8, 2008, a letter from HKEx, with the notice of the decision from HKEx to cancel the listing of the Company’s H Shares.
The GEM Listing Committee has decided that the listing of the H Shares of the Company on the Exchange be cancelled in accordance with Rule 9.14 of the GEM Listing Rules.
The Company’s legal agent has filed a petition on the decision.
On January 18, 2008, HKEx Review Committee notified the Company to attend a review meeting on February 26, 2008, at 4:30pm. The Company will propose a detailed and viable merger plan, the goal is to delay the de-listing and ultimately resume its listing.
As the judgment by Jilin Nong’an County Court, the Company’s former Chairman,
Mr. Feng, Zhenwen is sentenced of 3 years imprisonment for disclosing false financial statement and misappropriate the Company’s assets, the Company’s former
Chief Financial Officer, Ms. Li, Xiujie is sentenced of 4 years imprisonment for disclosing false financial statement and misappropriate the Company’s assets.
The Company has received, on January 8, 2008, a letter from HKEx, with the notice of the decision from HKEx to cancel the listing of the Company’s H Shares.
The GEM Listing Committee has decided that the listing of the H Shares of the Company on the Exchange be cancelled in accordance with Rule 9.14 of the GEM Listing Rules.
The Company’s legal agent has filed a petition on the decision.
On January 18, 2008, HKEx Review Committee notified the Company to attend a review meeting on February 26, 2008, at 4:30pm. The Company will propose a detailed and viable merger plan, the goal is to delay the de-listing and ultimately resume its listing.
As the judgment by Jilin Nong’an County Court on February 8, 2007, the Company’s
former Chairman, Mr. Feng, Zhenwen is sentenced of 2 years imprisonment and a fine of RMB20,000 for disclosing false financial statement, and 2 years imprisonment
for misappropriate the Company’s assets, the court has ordered a total of 3 years
imprisonment and a fine of RMB20,000 for Mr. Feng.
As the judgment by Jilin Nong’an County Court on February 8, 2007, the Company’s
former Chief Financial Officer, Ms. Li, Xiujie is sentenced of 2 years imprisonment and a fine of RMB20,000 for disclosing false financial statement, and 3 years imprisonment for misappropriate the Company’s assets, the court has ordered a total
years imprisonment and a fine of RMB20,000 for Ms. Li of 4
At the request of the Company, trading in the shares of the Company on the Stock Exchange was suspended with effect from 10:00 a.m. on 28 July 2005 and will remain suspended until further notice.
By order of the Board
Changchun Da Xing Pharmaceutical Company Limited
Guo Gan
____________
Director
Changchun, the PRC, 18 January 2008
As at the date of this announcement, the Board comprises Mr. Guo Gan only.
This announcement, for which the directors of Changchun Da Xing Pharmaceutical Company Limited collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to Changchun Da Xing Pharmaceutical Company Limited. The directors, having made all reasonable enquiries, confirm that, to the best of their knowledge and belief: (1) the information contained in this announcement is accurate and complete in all material respects and not misleading; (2) there are no other matters the omission of which would make any statement in this announcement misleading; and (3) all opinions expressed in this announcement have been arrived at after due and careful consideration and are founded on bases and assumptions that are fair and reasonable.
This announcement will remain on the “Latest Company Announcements” page on
the GEM Website at www.hkgem.com for at least 7 days from the date of its posting.